Miranda Jayne Toledano - Net Worth and Insider Trading

Miranda Jayne Toledano Net Worth

The estimated net worth of Miranda Jayne Toledano is at least $196,342 dollars as of 2024-11-09. Miranda Jayne Toledano is the CEO of Entera Bio Ltd and owns about 110,752 shares of Entera Bio Ltd (ENTX) stock worth over $190,493. Miranda Jayne Toledano is also the Director of NexGel Inc and owns about 1,819 shares of NexGel Inc (NXGL) stock worth over $5,848. Details can be seen in Miranda Jayne Toledano's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Miranda Jayne Toledano has not made any transactions after 2023-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Miranda Jayne Toledano

To

Miranda Jayne Toledano Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Miranda Jayne Toledano owns 5 companies in total, including Sorrento Therapeutics Inc (SRNE) , NexGel Inc (NXGL) , and Entera Bio Ltd (ENTX) among others .

Click here to see the complete history of Miranda Jayne Toledano’s form 4 insider trades.

Insider Ownership Summary of Miranda Jayne Toledano

Ticker Comapny Transaction Date Type of Owner
SRNE Sorrento Therapeutics Inc 2016-09-16 EVP-Corporate Development
NXGL NexGel Inc 2021-12-27 director
ENTX Entera Bio Ltd 2023-12-22 director
LIMIT LIMIT 2021-06-25 director
LIMIT LIMIT 2021-11-16 director

Miranda Jayne Toledano Latest Holdings Summary

Miranda Jayne Toledano currently owns a total of 2 stocks. Among these stocks, Miranda Jayne Toledano owns 110,752 shares of Entera Bio Ltd (ENTX) as of December 22, 2023, with a value of $190,493 and a weighting of 97.02%. Miranda Jayne Toledano also owns 1,819 shares of NexGel Inc (NXGL) as of December 27, 2021, with a value of $5,848 and a weighting of 2.98%.

Latest Holdings of Miranda Jayne Toledano

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTX Entera Bio Ltd 2023-12-22 110,752 1.72 190,493
NXGL NexGel Inc 2021-12-27 1,819 3.22 5,848

Holding Weightings of Miranda Jayne Toledano


Miranda Jayne Toledano Form 4 Trading Tracker

According to the SEC Form 4 filings, Miranda Jayne Toledano has made a total of 4 transactions in Entera Bio Ltd (ENTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Entera Bio Ltd is the acquisition of 23,952 shares on December 22, 2023, which cost Miranda Jayne Toledano around $17,006.

According to the SEC Form 4 filings, Miranda Jayne Toledano has made a total of 1 transactions in NexGel Inc (NXGL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NexGel Inc is the acquisition of 1,819 shares on December 27, 2021, which cost Miranda Jayne Toledano around $9,986.

Insider Trading History of Miranda Jayne Toledano

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Miranda Jayne Toledano Trading Performance

GuruFocus tracks the stock performance after each of Miranda Jayne Toledano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Miranda Jayne Toledano is 33.42%. GuruFocus also compares Miranda Jayne Toledano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Miranda Jayne Toledano within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Miranda Jayne Toledano's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Miranda Jayne Toledano

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.56 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 8.7 LIMIT LIMIT LIMIT LIMIT LIMIT

Miranda Jayne Toledano Ownership Network

Ownership Network List of Miranda Jayne Toledano

No Data

Ownership Network Relation of Miranda Jayne Toledano

Insider Network Chart

Miranda Jayne Toledano Owned Company Details

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

Miranda Jayne Toledano is the EVP-Corporate Development of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sorrento Therapeutics Inc Insider Transactions

No Available Data

Miranda Jayne Toledano Mailing Address

Above is the net worth, insider trading, and ownership report for Miranda Jayne Toledano. You might contact Miranda Jayne Toledano via mailing address: C/o Compass Therapeutics, Inc., 80 Guest Street, Suite 601, Boston Ma 02135.